Respiratory Infections News

Patients with HIV who were hospitalized with COVID-19 during the peak of the spring epidemic in New York City did not experience worse outcomes than patients without HIV who were hospitalized with COVID-19, researchers reported.

Donald Kaye, MD, MACP, an influential infectious diseases clinician and researcher and longtime Infectious Disease News Editorial Board Member, died July 4 at the age of 88, his family announced.

Using hepatitis C drugs sofosbuvir and daclatasvir in combination with standard care to treat patients with COVID-19 resulted in better 14-day recovery rates and a shorter hospital stay, according to data presented at AIDS 2020.

A small study of 31 pregnant women with SARS-CoV-2 infection provided data that are “strongly suggestive” of the possibility of in utero vertical transmission of the novel coronavirus, a researcher said.

More than 4,000 people have signed an online petition urging members of Congress to implement a national mandate that requires all Americans to wear masks or face coverings in public to stop the spread of COVID-19.

Several trials exploring radiation’s potential as a treatment for critically ill patients with COVID-19 are underway in the United States.

COVID-19 will set back the goal to end AIDS by 2030, stalling an already off-track goal even further, according to a presentation from the opening session of the AIDS 2020 virtual meeting.

Dispensed prescriptions of hydroxychloroquine in the U.S. increased 86.2%, while such prescriptions of chloroquine increased 158.6% from February to March 2020, data show.

On Monday, Gilead Sciences announced that remdesivir — one of the only recommended treatments for COVID-19 — will be available to governments of developed countries for $390 per vial.

A new study highlights significant variation in ventilator allocation guidelines among U.S. states, which could result in inequity in the allocation of mechanical ventilatory support during the COVID-19 pandemic.